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Endocannabinoids control male reproduction acting at central and local level via 
cannabinoid receptors. The cannabinoid receptor CB1 has been characterized in the 
testis, in somatic and germ cells of mammalian and non-mammalian animal models, 
and its activity related to Leydig cell differentiation, steroidogenesis, spermiogenesis, 
sperm quality, and maturation. In this short review, we provide a summary of the insights 
concerning neuroendocrine CB1 activity in male reproduction focusing on adult Leydig 
cell ontogenesis and steroid biosynthesis.
Keywords: CB1, endocannabinoids, Leydig cells, steroidogenesis, spermatogenesis, testis
inTRODUCTiOn
Since the identification and the cloning of cannabinoid receptor 1 (CB1) from mammalian brain 
(1, 2), the deep involvement of CB1 signaling in several physiological functions emerged (3, 4). 
Besides central control of processes, such as reproduction, neuroendocrine functions, stress, food 
intake, neurogenesis, memory, thermogenesis, and pain (3–7), CB1 exerts direct activity in male and 
female reproductive and non-reproductive cells and tissues (3, 4, 8–11). This membrane G-protein-
coupled receptor has the ability to bind endogenous cannabinoids [i.e., anandamide (AEA) and 
2-arachidonoylglycerol (2-AG)], phytocannabinoids [i.e., Δ9-tetrahydrocannabinol (THC), the main 
psychoactive constituent of Cannabis sativa] and synthetic antagonists and agonists [i.e., SR141716 
and HU-210, respectively] (8, 12). Its activity strongly depends on ligand availability whose tone 
is endogenously modulated by the fatty acid amide hydrolase (FAAH). Here, we provide a brief 
summary of the insights concerning direct/indirect effects of CB1 activity on adult Leydig cell (ALC) 
ontogenesis and steroid biosynthesis.
CB1 ACTiviTY AnD OnTOGeneSiS OF ALC
CB1 is expressed and functionally active early during the development, when it regulates embryonic 
and trophoblast stem cell survival, and the differentiation of several adult specialized tissues (13). CB1 
activity has been shown to regulate proliferation and differentiation of mesoderm-derived mesenchy-
mal stem cells, with a key role in cellular differentiation of several peripheral tissues including adipo-
cytes, osteoblasts, skeletal muscle, and epithelial cells (13). A key role for CB1 has further emerged 
in ALC development, in both rat and mouse (14). Ontogenesis of these cells occurs postnatally from 
undifferentiated mesenchymal-like stem cells localized in the interstitial compartment of testis. Four 
distinct stages of the ALC development have been identified and characterized: (i) the stem Leydig 
cells, i.e., spindle-shaped interstitial mesenchymal cells able of self-renewal,  differentiation, and 
replenishment of the Leydig cell niche; (ii) the progenitor Leydig cells deriving from stem Leydig cells 
and differentiating into (iii) immature Leydig cells; and (iv) the mature/ALCs originating from the 
immature ones through a single proliferation cycle (15). During postnatal development of rat testis 
(14), CB1 is expressed in the interstitial compartment from the early postnatal days. Later, with the 
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appearance of round spermatids, CB1 is localized in the tubular 
compartment. In interstitial cells, CB1 expression is related to stem 
and/or progenitor cells committed to differentiate into immature 
Leydig cells. Its expression shuts down in immature Leydig cells 
when these cells undergo proliferation to produce fully developed 
ALC (14). Afterward, CB1 results to be stably expressed in these 
steroid-secreting cells suggesting a direct effect in the modula-
tion of steroidogenesis. In agreement with these observations, 
CB1 activation inhibits basal testosterone secretion in vivo and 
in vitro (16), while its inactivation promotes the downregulation 
of neuroendocrine axis, decrease of testosterone and estradiol 
levels, and the development of few ALC as well, thus suggesting 
an involvement of CB1 in steroidogenesis and ALC ontogenesis 
(14, 16–19). Interestingly, as observed in adipocytes during their 
differentiation (13), CB1 seems to be positively related to differ-
entiation events supervising the ontogenesis of Leydig cells and 
negatively with respect to their proliferation.
CB1 ACTiviTY AnD PRODUCTiOn  
OF SeX HORMOneS
Hormonal milieu and a set of local modulators sustain the 
progression of spermatogenesis and the formation/release of 
high quality sperm (20). Thus, the testicular biosynthesis of 
testosterone –  the classical male hormone – primarily requires 
the release of hypothalamic gonadotropin-releasing hormone 
(GnRH), which in turn induces the release in the bloodstream of 
pituitary gonadotropins (21).
CB1 has a leading role in the production of sex hormones; both 
THC and AEA repress testosterone secretion via inhibition of 
GnRH and gonadotropins synthesis/release (3, 10, 11, 16, 22–29), 
whereas sex steroids affect CB1 expression and endocannabinoid 
levels in the anterior pituitary gland (30). As a consequence, 
inhibitory effects on neuroendocrine axis (10, 11, 18), sexual 
behavior (28), and sperm quality (3, 9, 18, 19, 31–34) have been 
observed. In testis, besides spermatids and Sertoli cells (14, 34, 
35), CB1 is expressed in the steroid-secreting ALC (14, 16, 36), 
thus suggesting direct effects on the modulation of ALC activity. 
Consistently, CB1 and the endovanilloid receptor TRPV1 exert 
direct, but opposite, effects on testicular GnRH signaling (36, 37), 
one of the main testicular bioregulators of spermatogenesis and 
steroidogenesis (21, 38, 39).
Thus, efforts to define the detailed molecular mechanisms to 
clarify how endocannabinoids regulate testosterone production 
in vertebrates have been made. In this respect, data from the 
anuran amphibian Pelophylax esculentus recently added insights 
in this intriguing story. In fact, in vitro incubations of frog testis 
and in vivo treatment with AEA have been carried out to ana-
lyze the expression of cytochrome P450 17α-hydroxylase/17,20 
lyase (cyp17) and 3β-hydroxysteroid dehydrogenase/D-5-4 
isomerase (3β-HSD), key enzymes in sex steroid biosynthe-
sis. Interestingly, the in  vivo treatment only had an effect on 
steroidogenesis, thus suggesting that the functionality of the 
hypothalamus–pituitary axis is essential to support the role 
of endocannabinoids in the regulation of steroidogenesis in 
amphibians (40). However, the decrease of cyp17 may involve 
receptors other than CB1 since SR141716 administration does 
not restore its expression to control level.
Since CB1 has the ability to regulate, directly or indirectly, 
the activity of hypothalamic GnRH [see review in Ref. (29, 
11)] in different cell lines (41), as well as in mammalian (24, 
42) and non-mammalian vertebrate species (25, 26, 43), and 
endocannabinoids are in sharp contrast with kisspeptins, the 
emerging positive regulators of GnRH system at both central 
and testicular level (44, 45). Their involvement in the control of 
ALC activity (45–47), in the regulation of estrogen-dependent 
reproductive functions (47), and spermatogenesis progression 
(47) has recently been suggested. Hence, the last insight in CB1 
activity and testosterone production is considering kisspeptin 
system as new cannabinoid target in the hypothalamus. In fact, 
CB1 activation induces the downregulation of kiss1, the gene 
encoding kisspeptin, in male rats under stress condition (48) 
but also in frog testis, under physiological conditions (49). In 
particular, in frog, the molecular mechanism has recently been 
elucidated. In fact, in  vivo administration of AEA, via CB1, 
decreases the transcription level of GnRH, ligands and recep-
tors, in the diencephalon, but also negatively affects Kiss1 and 
kisspeptin receptor GPR54 in both diencephalon and testis. 
As a consequence, intratesticular testosterone level decreases 
and estradiol production increases due to the parallel increase 
of the P450 aromatase (cyp19) mRNA/protein (49). Therefore, 
the endocrine route well integrates with the local circuitry that 
modulates AEA tone by FAAH, the major checkpoint of endo-
cannabinoid signaling in vertebrates occurring via estrogen 
biosynthesis in both mammalian and non-mammalian testis 
(49–51). In fact, in vitro incubations with AEA or 17β-estradiol 
both increase the FAAH levels, and AEA effects are fully counter-
acted by the anti-estrogen ICI182780 (49). Therefore, high AEA 
tone, via cyp19, induces estradiol biosynthesis with subsequent 
FAAH production and AEA hydrolysis. Thus, AEA may control 
testis physiology – centrally – acting through kisspeptin system 
and  –  locally  –  modulating its tone via the biosynthesis of 
estradiol, which in turn targets FAAH protein (49). The direct 
activity of AEA exerted via CB1 on cyp19 is confirmed by the 
characterization of CB1−/− mice, a model that efficiently synthe-
sizes LH but shows low LH, testosterone, and estradiol levels in 
the bloodstream (16, 18, 19). Besides the impairment of GnRH 
signaling (18, 19) and the fewer ALC (14) responsible for LH drop 
and testosterone depletion, respectively, CB1−/− mice express low 
cyp19, but normal 3β-HSD mRNA levels (18, 19), suggesting a 
direct CB1 activity in the control of estradiol biosynthesis.
CLOSinG ReMARKS
The use of mammalian and non-mammalian animal models 
should be considered useful tool for studying the involvement 
of endocannabinoids in the regulation of evolutionarily con-
served biological processes such as spermatogenesis (25, 39, 52). 
Endocannabinoid system has been characterized in Sertoli and 
germ cells, while very few information about ALC are available. 
Since the central role played by ALC in the regulation of testicular 
activity via endocannabinoid system, we argue that studies should 
be addressed in this direction.
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